Catalent

Articles

The management of lung cancer brain metastases has seen significant advancements, with a focus on personalized treatment strategies. The integration of targeted therapies and immunotherapies has improved patient outcomes, offering more effective and less invasive options compared to traditional methods. Stereotactic radiosurgery and whole-brain radiation therapy remain crucial, but their roles are evolving with the advent of novel systemic treatments. Multidisciplinary collaboration is essential for optimizing care, ensuring that treatment plans are tailored to individual patient profiles and disease characteristics, ultimately enhancing survival rates and quality of life.

This scientific poster showcases how GPEx® Lightning enables precise, digital control of gene expression for complex biologics. By leveraging targeted integration into ~200 Dock sites and a single optimized construct, developers can fine-tune gene ratios for co-expression of enzymes, cofactors, and multi-chain proteins. Learn how this approach streamlines screening, boosts titers, and shortens timelines—even for products with unknown stoichiometry.

Digital Expression Control with GPEx® Lightning: Enabling Complex Biologics in CHO Cells

I'm sorry, but it seems there is no article text provided for me to summarize and analyze. Please provide the text of the article, and I will be happy to assist you

This whitepaper explores biocapacitance measurement as a process analytical technology (PAT) for real-time biomass monitoring in mammalian and microbial systems. Learn how this QbD-aligned approach enhances upstream process control, reduces reliance on post-batch testing, and supports continuous manufacturing. Three real-world applications illustrate its impact on process visibility and efficiency.

Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing 

I'm sorry, but it seems there is no article provided for me to summarize and extract key takeaways from. Please provide the text of the article, and I'll be happy to assist you

Discover how Catalent’s GPEx® Lightning platform revolutionizes cell line development for complex biologics. This executive summary highlights how the platform enables rapid, high-titer expression of multispecific antibodies and other challenging proteins—accelerating timelines, improving production efficiency, and supporting commercial-scale manufacturing. Learn how tunable expression and digital control empower your team to overcome development bottlenecks and drive innovation in next-generation biologics.

Unlocking Speed and Scalability in Biologics: GPEx® Lightning Executive Overview

Catalent’s GPEx® Lightning platform delivers stable, high-yield cell lines with unmatched speed—achieving titers up to 15g/L for mAbs and 11g/L for bispecifics. With 25-day pool generation and up to 12 weeks saved on development timelines, this offering sheet outlines key performance metrics and benefits that make GPEx® Lightning a game-changer for biologics developers.

Accelerate Cell Line Development with GPEx® Lightning: Speed, Stability, and Industry-Leading Titers 

I'm sorry, but it seems there is no article provided for me to summarize and extract key takeaways from. Could you please provide the text of the article

Accelerating Complex Drug Development With Precision Micronization  

This session will explore best practices for sourcing and managing comparator products in clinical trials. It is designed to help sponsors and clinical supply professionals navigate the complexities of comparator selection, procurement, and distribution, with insights from Catalent’s global experience.

https://www.pharmtech.com/pt_w/clinical-success

Catalent’s global sourcing experts invite you to a strategic webinar focused on comparator selection and supply optimization for clinical trials. This session will provide actionable insights into how sponsors can streamline sourcing, mitigate risk, and ensure regulatory compliance across global studies. It will also explore real-world case studies to see how sourcing strategies have delivered measurable cost savings and operational efficiencies. It is designed to help sponsors and clinical supply professionals navigate the complexities of comparator selection, procurement, and distribution, with insights from Catalent’s global experience.

How to optimize comparator sourcing for speed, reliability, and compliance.

Risk mitigation techniques to avoid costly delays and disruptions.

Real-world case studies demonstrating cost savings and operational excellence.

Supply Chain; Clinical Supply/Supplies; Logistics; Operations Quality; Materials Management; Value Chain; Technical Operations; Sourcing Management; Supplier Management; Procurement; Clinical Operations; Packaging and Labeling; Vendor Management; Clinical Trial Supply; Strategic Sourcing; Global Category Manager (Clinical Services or R&D Procurement); External Manufacturing or CDMO Management; Program Manager, Project Manager, Consultants, Trial Sponsors, CROs

Global Director of Comparator Services
Catalent

Mark Ignaczak is the Global Director of Comparator Services at Catalent, overseeing global commercial drug sourcing. He develops strategies to improve comparator sourcing and clinical supply solutions worldwide, ensuring timely, cost-effective delivery. With more than 20 years of experience in pharmaceuticals and having supported more than 15 drug approvals, Ignaczak brings expertise in commercial operations and client engagement while focusing on innovation and operational excellence for clinical trials.

Account Director, Comparator Services
Catalent

Pearl Mensah has recently joined Catalent as Account Director of Comparator Services, where she plays a pivotal role in supporting global clinical trial supply strategies. Mensah brings a wealth of experience in consultative sales, business development, and client engagement from across the life sciences sector. She holds a BA in philosophy, an MA in educational leadership and administration, and an MS in human resource development from Villanova University.


Webcasts

Webinar Date/Time:  Tue, Dec 9, 2025 11:00 AM EST